Inventor
SHAW KENNETH
US59 patents
⚠️ This page may combine multiple inventors who share the name “SHAW KENNETH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEUROGEN CORP
32 patentsUS5840888ANov 24, 1998
Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GABA brain receptor ligands
NEUROGEN CORP63 citations96
US5693801ADec 2, 1997
Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GaBa brain receptor ligands
NEUROGEN CORP63 citations96
US5266698ANov 30, 1993
Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GABA brain receptor ligands
NEUROGEN CORP73 citations96
US5130430AJul 14, 1992
2-substituted imidazoquinoxaline diones, a new class of gaba brain receptor ligands
NEUROGEN CORP58 citations96
US6515140B2Feb 4, 2003
Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
NEUROGEN CORP33 citations93
US6268496B1Jul 31, 2001
Certain imidazoquinoxalines: a new class of GABA brain receptor ligands
NEUROGEN CORP22 citations93
US6211365B1Apr 3, 2001
Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
NEUROGEN CORP29 citations93
US6080873AJun 27, 2000
Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
NEUROGEN CORP29 citations93
US6013799AJan 11, 2000
Certain cycloalkyl imidazopyrimides, a new class of gaba brain receptor ligands
NEUROGEN CORP29 citations93
US5804686ASep 8, 1998
fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
NEUROGEN CORP30 citations93
US5696260ADec 9, 1997
Certain cycloalkyl imidazopyrimidines, a new class of gaba brain receptor ligands
NEUROGEN CORP28 citations93
US5604235AFeb 18, 1997
Certain pyrroloquinolinones; a new class of gaba brain receptor ligands
NEUROGEN CORP24 citations93
US5426186AJun 20, 1995
Certain cycloalkyl imidazopyrimidines, a new class of GABA brain receptor ligands
NEUROGEN CORP20 citations93
US5243049ASep 7, 1993
Certain pyrroloquinolinones: a new class of GABA brain receptor ligands
NEUROGEN CORP39 citations93
US5185446AFeb 9, 1993
Certain cycloalkyl imidazopyrimidines; a new class of gaba brainreceptor ligands
NEUROGEN CORP28 citations93
US6511987B1Jan 28, 2003
Bicyclic and tricyclic heteroaromatic compounds
NEUROGEN CORP16 citations92
US6380210B1Apr 30, 2002
Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors
NEUROGEN CORP37 citations92
US6177569B1Jan 23, 2001
Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
NEUROGEN CORP34 citations92
US6552037B2Apr 22, 2003
2-Substituted imidazo[1,2-A]pyridine derivatives
NEUROGEN CORP17 citations84
US5908932AJun 1, 1999
Certain pyrroloquinolinones; a new class of GABA brain receptor
NEUROGEN CORP16 citations82
US6723332B2Apr 20, 2004
Oxomidazopyridine-carboxamides
NEUROGEN CORP11 citations74
US6451809B2Sep 17, 2002
Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
NEUROGEN CORP12 citations73
US6420365B1Jul 16, 2002
Imidazopyridines and related derivatives as selective modulators of bradykinin B2 receptors
NEUROGEN CORP9 citations72
US6358949B1Mar 19, 2002
Aryl and hetroaryl fused aminoalkyl-imidazole derivatives: selective modulators of bradykinin B2 receptors
NEUROGEN CORP10 citations72
US5744602AApr 28, 1998
Certain imidazoquinoxalines; a new class of GABA brain receptor ligands
NEUROGEN CORP15 citations67
US7326709B2Feb 5, 2008
Bicyclic and tricyclic heteroaromatic compounds
NEUROGEN CORP2 citations63
US7109351B1Sep 19, 2006
Fused pyrrolecarboxamides; GABA brain receptor ligands
NEUROGEN CORP5 citations63
US7053093B2May 30, 2006
Bicyclic and tricyclic hetroaromatic compounds
NEUROGEN CORP2 citations63
US6528649B2Mar 4, 2003
Imidazoloisoquinolines
NEUROGEN CORP4 citations63
US6972293B2Dec 6, 2005
Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors
NEUROGEN CORP3 citations62
US6627624B1Sep 30, 2003
Aryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors
NEUROGEN CORP4 citations62
US6509366B2Jan 21, 2003
Substituted imidazoles as selective modulators of Bradykinin B2 receptors
NEUROGEN CORP7 citations62
MARINUS PHARMACEUTICALS
8 patentsUS8618087B2Dec 31, 2013
Solid ganaxolone formulations and methods for the making and use thereof
MARINUS PHARMACEUTICALS35 citations98
US9056116B2Jun 16, 2015
Liquid ganaxolone formulations and methods for the making and use thereof
MARINUS PHARMACEUTICALS26 citations96
US8022054B2Sep 20, 2011
Liquid ganaxolone formulations and methods for the making and use thereof
MARINUS PHARMACEUTICALS30 citations96
US7858609B2Dec 28, 2010
Solid ganaxolone formulations and methods for the making and use thereof
MARINUS PHARMACEUTICALS46 citations96
US9452176B2Sep 27, 2016
Solid ganaxolone compositions and methods for the making and use thereof
MARINUS PHARMACEUTICALS8 citations92
US9029355B2May 12, 2015
Solid ganaxolone compositions and methods for the making and use thereof
MARINUS PHARMACEUTICALS22 citations92
US8367651B2Feb 5, 2013
Solid ganaxolone formulations and methods for the making and use thereof
MARINUS PHARMACEUTICALS22 citations92
US9017728B2Apr 28, 2015
Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof
MARINUS PHARMACEUTICALS7 citations84
SHAW KENNETH
3 patentsUS8318714B2Nov 27, 2012
Liquid ganaxolone formulations and methods for the making and use thereof
SHAW KENNETH22 citations92
US9760936B1Sep 12, 2017
Method of and system for purchasing an item using contributions from multiple people
SHAW KENNETH40 citations89
US8455002B2Jun 4, 2013
Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof
SHAW KENNETH11 citations83
COVIDIEN LP
2 patentsMARINUS PHARMACEUTICALS INC
2 patentsMALKOWSKI JAROSLAW T
1 patentIBM
1 patentTUSK INC
1 patentShowing the top 50 of 59 patents by PatentIndex Score.